ENGN FY 2025 Earnings — enGene Holdings Inc. Revenue & Financial Results | Market Cap Arena

ENGNenGene Holdings Inc.

$359M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$509,000

Operating Income

-$123M

Net Income

$117M

EPS (Diluted)

$-2.29

Cash Flow

Operating Cash Flow

-$99M

Free Cash Flow

-$101M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$221M

Total Liabilities

$54M

Stockholders' Equity

$168M

Cash & Equivalents

$50M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$509,000	-$323,000	-57.6%
Operating Income	-$123M	$62M	-297.7%
Net Income	$117M	-$55M	+312.7%